AMAG Pharmaceuticals Inc (AMAG)

24.40
NASDAQ : Health Care
Prev Close 24.60
Day Low/High 24.07 / 24.65
52 Wk Low/High 17.92 / 36.83
Avg Volume 955.20K
Exchange NASDAQ
Shares Outstanding 34.94M
Market Cap 859.51M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics

Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics

Pacific Biosciences of California, AMAG Pharmaceuticals and Global Blood Therapeutics were among the biotech stock movers in premarket trading on Tuesday.

AMAG Pharmaceuticals Stock Sees Short Interest Make 20.3% Move

AMAG Pharmaceuticals Stock Sees Short Interest Make 20.3% Move

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 1,238,470 share increase in total short interest for AMAG Pharmaceuticals, Inc. , to 7,338,003, an increase of 20.30% since 01/13/2017.

Palatin Technologies Announces Closing Of License Agreement With AMAG Pharmaceuticals For North American Rights To Rekynda™

Palatin Technologies Announces Closing Of License Agreement With AMAG Pharmaceuticals For North American Rights To Rekynda™

Will Also Report Second Quarter 2017 Results and Discuss Next Steps in its Development Programs

AMAG Pharmaceuticals is Now Oversold (AMAG)

AMAG Pharmaceuticals is Now Oversold (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMAG Pharmaceuticals Announces Positive Topline Results From Definitive Pharmacokinetic Study For Makena Subcutaneous Administration

AMAG Pharmaceuticals Announces Positive Topline Results From Definitive Pharmacokinetic Study For Makena Subcutaneous Administration

Supplemental new drug application on track for second quarter 2017 filing

Oversold Conditions For AMAG Pharmaceuticals (AMAG)

Oversold Conditions For AMAG Pharmaceuticals (AMAG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

AMAG Pharmaceuticals Doubles Support Of Prematurity Prevention Research

AMAG Pharmaceuticals Doubles Support Of Prematurity Prevention Research

Grant awards in 2016 support promising research aimed at improving the health of mothers and babies

AMAG Pharmaceuticals (AMAG) Shares Cross Below 200 DMA

AMAG Pharmaceuticals (AMAG) Shares Cross Below 200 DMA

In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $23.98, changing hands as low as $23.80 per share.